 | Up a level |
Navi, Babak B; Zhang, Cenai; Miller, Benjamin; Cushman, Mary; Kasner, Scott E; Elkind, Mitchell S V; Tirschwell, David L; Longstreth, W T; Kronmal, Richard A; Beyeler, Morin; Elm, Jordan; Zweifler, Richard M; Tarsia, Joseph; Cereda, Carlo W; Bianco, Giovanni; Costamagna, Gianluca; Michel, Patrik; Broderick, Joseph P; Gladstone, David J; Kamel, Hooman; ... (2024). Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial. JAMA neurology, 81(9), pp. 958-965. American Medical Association 10.1001/jamaneurol.2024.2404
Lemmens, Robin; Hamilton, Scott A; Liebeskind, David S; Tomsick, Tom A; Demchuk, Andrew M; Nogueira, Raul G; Marks, Michael P; Jahan, Reza; Gralla, Jan; Yoo, Albert J; Yeatts, Sharon D; Palesch, Yuko Y; Saver, Jeffrey L; Pereira, Vitor M; Broderick, Joseph P; Albers, Gregory W; Lansberg, Maarten G (2016). Effect of endovascular reperfusion in relation to site of arterial occlusion. Neurology, 86(8), pp. 762-770. Lippincott Williams & Wilkins 10.1212/WNL.0000000000002399
Broderick, Joseph P; Schroth, Gerhard (2013). What the SWIFT and TREVO II Trials Tell Us About the Role of Endovascular Therapy for Acute Stroke. Stroke, 44(6), pp. 1761-4. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/STROKEAHA.113.000740
